Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

How should health care providers inform about palliative sedation? A qualitative study with palliative care professionals

How should health care providers inform about palliative sedation? A qualitative study with... INTRODUCTIONPalliative sedation (PS) is a treatment used in palliative care to relieve severe distress in terminally ill patients. It consists of the monitored use of medications intended to induce a state of decreased or absent awareness in order to relieve the burden of otherwise treatment‐refractory suffering in a manner that is ethically acceptable to the patient, family and health care providers (Cherny & Radbruch, 2009). Although PS and euthanasia may concern the same patient population, they are considered as fundamentally different by many palliative care professionals (Gurschick et al., 2015; Materstvedt, 2012; Radbruch et al., 2016). Indeed, PS intends to relieve the symptoms and not to hasten or cause death. It's choice of drug and dosage is proportionate to the severity of symptoms. Death of the patient is not considered a criterion of success of the treatment (Claessens et al., 2008; Materstvedt, 2012). Finally, studies have shown that correctly administered PS does not hasten death but can even delay it (Beller et al., 2015; Maltoni et al., 2012; Schildmann & Schildmann, 2014; Swart et al., 2012).Depending on patients' needs, depth of PS can be mild or deep, and it can be temporary or continuous until death (SFAP, 2017; Swart et al., 2012). Population‐wide studies in Europe have shown a significant variation http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

How should health care providers inform about palliative sedation? A qualitative study with palliative care professionals

Download PDF
9 pages

Loading next page...
 
/lp/wiley/how-should-health-care-providers-inform-about-palliative-sedation-a-zHdwz5hPRW

References (51)

Publisher
Wiley
Copyright
© 2022 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.13602
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONPalliative sedation (PS) is a treatment used in palliative care to relieve severe distress in terminally ill patients. It consists of the monitored use of medications intended to induce a state of decreased or absent awareness in order to relieve the burden of otherwise treatment‐refractory suffering in a manner that is ethically acceptable to the patient, family and health care providers (Cherny & Radbruch, 2009). Although PS and euthanasia may concern the same patient population, they are considered as fundamentally different by many palliative care professionals (Gurschick et al., 2015; Materstvedt, 2012; Radbruch et al., 2016). Indeed, PS intends to relieve the symptoms and not to hasten or cause death. It's choice of drug and dosage is proportionate to the severity of symptoms. Death of the patient is not considered a criterion of success of the treatment (Claessens et al., 2008; Materstvedt, 2012). Finally, studies have shown that correctly administered PS does not hasten death but can even delay it (Beller et al., 2015; Maltoni et al., 2012; Schildmann & Schildmann, 2014; Swart et al., 2012).Depending on patients' needs, depth of PS can be mild or deep, and it can be temporary or continuous until death (SFAP, 2017; Swart et al., 2012). Population‐wide studies in Europe have shown a significant variation

Journal

European Journal of Cancer Care – Wiley

Published: Sep 1, 2022

Keywords: discussion; end‐of‐life care; guidelines; information; palliative care; palliative sedation

There are no references for this article.